VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-04-26
DOI
10.3389/fphar.2022.874235
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Survival-Related Competitive Endogenous RNA Network of Prognostic lncRNAs, miRNAs, and mRNAs in Wilms Tumor
- (2021) HengChen Liu et al. Frontiers in Oncology
- The human VRK1 chromatin kinase in cancer biology
- (2021) Ignacio Campillo-Marcos et al. CANCER LETTERS
- Phosphorylation of vaccinia-related kinase 1 at threonine 386 transduces glucose stress signal in human liver cells
- (2020) Kosuke Yokobori et al. BIOSCIENCE REPORTS
- A kinome-wide shRNA screen uncovers vaccinia-related kinase 3 (VRK3) as an essential gene for diffuse intrinsic pontine glioma survival
- (2019) Claudia Silva-Evangelista et al. ONCOGENE
- VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes
- (2019) Elena Martín-Doncel et al. Scientific Reports
- Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway
- (2019) Tianhua Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- High expression of VRK1 is related to poor prognosis in glioma
- (2018) Zhiyun Ben et al. PATHOLOGY RESEARCH AND PRACTICE
- Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells
- (2018) Aye M. Mon et al. PLoS One
- VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma
- (2017) Zhen-Chuan Liu et al. Oncotarget
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study
- (2016) Laura del Puerto-Nevado et al. BMC CANCER
- A genetic view of laryngeal cancer heterogeneity
- (2016) María José de Miguel-Luken et al. CELL CYCLE
- Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
- (2016) Rico D. Bense et al. JNCI-Journal of the National Cancer Institute
- High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma
- (2016) Wei Huang et al. PATHOLOGY RESEARCH AND PRACTICE
- Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
- (2016) H. Raza Ali et al. PLOS MEDICINE
- Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
- (2016) Rico D. Bense et al. JNCI-Journal of the National Cancer Institute
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Grainyhead-like 2 Promotes Tumor Growth and is Associated with Poor Prognosis in Colorectal Cancer
- (2015) Yingjun Quan et al. Journal of Cancer
- High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer
- (2014) Jens Reumert Laurberg et al. BMC CANCER
- Screening of Hub Genes and Pathways in Colorectal Cancer with Microarray Technology
- (2014) Yonggang Wang et al. PATHOLOGY & ONCOLOGY RESEARCH
- Luteolin Suppresses Cancer Cell Proliferation by Targeting Vaccinia-Related Kinase 1
- (2014) Ye Seul Kim et al. PLoS One
- Human VRK2 (Vaccinia-related Kinase 2) Modulates Tumor Cell Invasion by Hyperactivation of NFAT1 and Expression of Cyclooxygenase-2
- (2012) Marta Vázquez-Cedeira et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
- (2012) Farhad Azimi et al. JOURNAL OF CLINICAL ONCOLOGY
- Macro Histone H2A1.2 (MacroH2A1) Protein Suppresses Mitotic Kinase VRK1 during Interphase
- (2011) Wanil Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The C/H3 Domain of p300 Is Required to Protect VRK1 and VRK2 from their Downregulation Induced by p53
- (2008) Alberto Valbuena et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started